. 2019 Oct 16;9(10):230. doi: 10.3390/metabo9100230

Table 2.

Descriptive and exercise characteristics in four consecutive training phases in futsal players (n = 11), endurance athletes (n = 11), sprinters (n = 11), and control group (n = 11).

	Transition	General	Specific	Competition	ANOVA *
Body Mass (kg)
Futsal Players	75.8 ± 6.9	76.9 ± 7.0	77.6 ± 7.8 ^a	77.9 ± 7.4 ^a	0.006
Endurance	74.6 ± 8.1	73.1 ± 7.6 ^†	73.7 ± 6.7 ^†	73.2 ± 7.3 ^†	0.078
Sprinters	81.6 ± 5.5	82.8 ± 5.4	82.7 ± 5.6	83.3 ± 6.1 ^a	0.009
Control group	77.2 ± 7.9	77.8 ± 8.0	76.9 ± 7.6	76.8 ± 7.0	0.295
ANOVA **	0.125	0.022	0.039	0.014
Total-body SMM (kg)
Futsal Players	33.0 ± 3.0 ^†	33.9 ± 3.6 ^†,a	34.1 ± 3.3 ^†,a	34.2 ± 3.2 ^†,a	0.001
Endurance	32.9 ± 3.6 ^†	32.8 ± 3.3 ^†	33.1 ± 3.3 ^†	33.0 ± 3.2 ^†	0.672
Sprinters	39.1 ± 3.7	40.5 ± 3.6	40.4 ± 3.8	41.4 ± 4.6 ^a	0.002
Control group	33.3 ± 3.1 ^†	33.5 ± 3.2 ^†	33.0 ± 3.6 ^†	33.5 ± 3.6 ^†	0.335
ANOVA **	0.000	0.000	0.000	0.000
Total-body fat (%)
Futsal Players	17.4 ± 3.0 ^†	16.4 ± 2.1 ^†	16.7 ± 2.7 ^†	17.1 ± 2.3 ^†	0.391
Endurance	16.1 ± 2.6	14.0 ± 2.7 ^a	14.5 ± 2.3 ^†,a	14.2 ± 2.1 ^†,a	0.002
Sprinters	12.6 ± 2.2	11.0 ± 2.0 ^a	10.8 ± 1.9 ^a	10.6 ± 1.8 ^a	0.000
Control group	18.4 ± 3.9 ^†	18.5 ± 4.2 ^‡,†	18.2 ± 3.7 ^‡,†	17.2 ± 4.2 ^†	0.315
ANOVA **	0.000	0.000	0.000	0.000
LA_rest (mmol·L⁻¹)
Futsal Players	1.4 ± 0.4	1.2 ± 0.2	1.0 ± 0.2 ^a	0.8 ± 0.2 ^a,b	0.000
Endurance	1.2 ± 0.3	1.0 ± 0.2	1.0 ± 0.2	0.9 ± 0.1 ^a	0.006
Sprinters	1.4 ± 0.6	1.4 ± 0.5	1.2 ± 0.4	0.9 ± 0.2	0.023
Control group	1.3 ± 0.3	1.4 ± 0.3	1.2 ± 0.3	1.1 ± 0.2 ^§,‡,b	0.015
ANOVA **	0.652	0.033	0.057	0.002
LA_max (mmol·L⁻¹)
Futsal Players	11.6 ± 2.2	11.2 ± 2.9	10.8 ± 2.4	9.9 ± 1.5	0.065
Endurance	11.2 ± 1.8	9.9 ± 2.1	10.2 ± 1.9	10.1 ± 1.5	0.135
Sprinters	10.7 ± 1.9	10.8 ± 2.2	9.6 ± 1.9	10.0 ± 1.4	0.026
Control group	10.7 ± 1.4 ^b	11.6 ± 1.8	10.2 ± 1.9 ^b	10.6 ± 2.1 ^b	0.001
ANOVA **	0.543	0.319	0.575	0.784
VO₂max (ml·kg⁻¹·min⁻¹)
Futsal Players	55.81 ± 3.94 ^‡	55.57 ± 2.81 ^‡	57.04 ± 2.18	58.47 ± 2.06 ^‡,†	0.063
Endurance	64.58 ± 3.52	65.26 ± 7.81	67.72 ± 3.15	66.81 ± 4.66	0.392
Sprinters	52.53 ± 4.32 ^‡	53.01 ± 4.19 ^‡	52.88 ± 3.92 ^‡	52.91 ± 3.92 ^‡	0.932
Control group	57.92 ± 3.42 ^‡,†	57.38 ± 4.25 ^‡	56.66 ± 3.08 ^‡	55.96 ± 3.47 ^‡	0.128
ANOVA **	0.000	0.000	0.007	0.000

Abbreviations: SMM, skeletal muscle mass; LA_rest, resting lactate concentration; LA_max, maximal lactate concentration; VO₂max, maximal oxygen uptake. Values are means ± SD. * one-way ANOVA between examinations within group; ** one-way ANOVA between groups at the same examination period. ^§ Significantly different from FU. ^‡ Significantly different from EN. ^† Significantly different from SP. ^a Significantly different from transition phase. ^b Significantly different from general preparation phase. ^c Significantly different from specific preparation phase.